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Abstract: In view of the increasing interest in natural antimicrobial molecules, this study screened 
the ability of Thymus capitatus (TC) essential oil and Citrus limon var. pompia (CLP) extract as raw 
extracts or incorporated in vesicular nanocarriers against Streptococcus mutans and Candida albicans. 
After fingerprint, TC or CLP were mixed with lecithin and water to produce liposomes, or different 
ratios of water/glycerol or water/propylene glycol (PG) to produce glycerosomes and penetration 
enhancer vesicles (PEVs), respectively. Neither the raw extracts nor the nanovesicles showed 
cytotoxicity against human gingival fibroblasts at all the concentrations tested (1, 10, 100 μg/mL). 
The disc diffusion method, MIC-MBC/MFC, time-kill assay, and transmission electron microscopy 
(TEM) demonstrated the highest antimicrobial potential of TC against S. mutans and C. albicans. The 
very high presence of the phenol, carvacrol, in TC (90.1%) could explain the lethal effect against the 
yeast, killing up to 70% of Candida and not just arresting its growth. CLP, rich in polyphenols, acted 
in a similar way to TC in reducing S. mutans, while the data showed a fungistatic rather than a 
fungicidal activity. The phospholipid vesicles behaved similarly, suggesting that the transported 
extract was not the only factor to be considered in the outcomes, but also their components had an 
important role. Even if other investigations are necessary, TC and CLP incorporated in nanocarriers 
could be a promising and safe antimicrobial in caries prevention. 
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1. Introduction 
As proposed in the “ecological plaque hypothesis”, a carious lesion develops under changed 
environmental conditions, producing a corresponding disturbance to the stability of the resident 
microflora [1]. Changes occur when the frequency of fermentable dietary carbohydrate intake is 
increased. In such a situation, the biofilm spends more time at low pH, allowing Streptococcus mutans 
to proliferate at the expense of the resident community. S. mutans contributes to the lowering of the 
pH and the growth of acidogenic species at the expense of the resident microflora [2,3]. This 
breakdown disrupts the de- and remineralization in teeth, pushing the equilibrium toward 
demineralization and tooth cavities. Candida albicans can appear in cariogenic biofilm when bonded 
to S. mutans, thus increasing the virulence of the biofilm and resulting in severe and recurrent caries 
in early childhood [4] and in salivary disorders [5]. 
In addition to fluorine, the capacity of which has been widely recognized as an anti-carious agent 
[5–7], a broad range of chemical agents have been used to reduce the cariogenicity of S. mutans in the 
biofilm [8]. Nevertheless, the increasing phenomenon of antibiotic resistance [9] necessitates the 
study of alternative therapeutic strategies to chemicals, and new substances, including natural 
extracts, have been widely investigated [10,11]. The antimicrobial capacity of biomolecules relies on 
the presence of chemical groups with distinct biosynthetic origins: Phenolic and polyphenols, 
terpenoids, alkaloids, lectins and polypeptides, and polyacetylenes [12,13]. In particular, terpenoids 
and flavonoids have demonstrated great potential against cariogenic bacteria and C. albicans [14–17]. 
Recently, encapsulation of natural molecules within lipid-based carriers has shown to increase their 
efficacy by protecting them from degradation [18], enhancing bioavailability [19], and delivering 
adequate concentration to the target tissues [20] or microorganisms [21]. 
Within lipid-based carriers, lamellar vesicles are composed of phospholipids, drugs, and, in 
some cases, additive components, such as surfactants and co-solvents. The identification of the 
appropriate combination of vesicle components is a matter of intensive study. Phospholipid 
nanovesicles having high concentrations of glycerol as co-solvent (glycerosomes), and penetration 
enhancer-containing vesicles (PEVs) have demonstrated a high efficacy in carrying polyphenols. 
Indeed, PEVs were able to promote the penetration of the active components of S. insularis essential 
oil in the skin, greater than that of control liposomes, and similarly, glycerosomes potentiated the 
aptitude of the pompia extract to counteract oxidative stress in both keratinocytes and fibroblasts, 
preventing their death [22,23]. Their versatility and absence of toxicity can make them suitable 
carriers for the delivery of antimicrobial molecules. 
Among the enormous number of plant genera, various types of Thymus of the Lamiaceae family, 
and Citrus of the Rutaceae family have attracted attention for their bactericidal, fungicidal, and anti-
inflammatory activities [14,16,24]. In this work, Thymus capitatus (TC) and Citrus limon var. pompia 
(CLP), typical species of Sardinia (Italy), were investigated. A great concentration of phenols has been 
identified in the essential oil of TC [25]. In addition, the high availability of flavonoids rich in 
polyphenolic rings [23] suggest great antimicrobial capacity for CLP. 
Thus, in view of the increasing general interest in developing antimicrobials of natural origins, 
which could, more specifically, be useful in caries prevention, this study aimed to assess the 
antimicrobial efficacy of TC essential oil and CLP extract used as raw extracts or incorporated in 
vesicular nanocarriers in the neutralization of S. mutans and C. albicans. 
2. Materials and Methods 
2.1. Plant Collection 
The aerial parts (flowers, leaves and stems) of TC were collected in North Sardinia (40°82′02”N; 
8°63′10”E) from wild plants growing on marl soil over limestone. Harvesting took place in mid-June 
when the plants were fully flowering, in the so-called “balsamic time”, which is the period of the 
plant growth cycle in which essential oil and/or specific metabolite production reaches its maximum. 
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CLP fruit was harvested in January from plants growing on alluvial soil located near Cedrino 
river in Orosei (40°37′75”N; 9°71′23”E). After harvest, the TC and CLP were immediately stored at 5 
°C and processed within the following 24 h, as previously reported [23]. 
2.2. Extraction Procedures 
The essential oil was extracted from the fresh aerial parts of TC. The collected parts were put 
into a heated (30 °C) ventilated armoire (Memmert 260, Spinea, Venice, Italy) until dry. Then, 150 g 
of the dried parts were powdered by milling the matrix with a ball-mill (Retsh Emax, Retsch GmbH, 
Haan, Germany) for 20 min, and steam-distilled for 2 h using a circulatory Clevenger-type apparatus 
(Merk KGaA, Dormstadt, Germany) according to the European Pharmacopoeia. The distillate was 
then dried over anhydrous sodium sulphate and the obtained essential oil was stored at low 
temperature until use. The chemical characterization of TC was conducted using a solution of the 
essential oil in hexane. 
CLP fruit rind (flavedo and albedo) was removed within 24 h of harvest and subjected to 
extraction as previously reported [23]. Briefly, the rind was minced with a knife, dried, powdered, 
and dispersed in a water/ethanol (50:50 v/v) blend. After centrifugation, the supernatant was 
collected, ethanol was removed with a rotovapor (Buchi R 300, Buchi, Cornaredo, Italy), while water 
was removed by freeze-drying. A fine yellow powder was obtained, and vacuum stored until use. 
The chemical characterization of the extract was conducted using the powder dissolved in methanol 
(1:100 w/v). 
2.3. Identification of TC and CLP Components 
2.3.1. GC-MS Analysis of TC Essential Oil 
The GC-MS analysis of a TC essential oil solution in hexane (dilution ratio 1:200 v/v, injection 
volume 1 μL) was carried out by using an Agilent 7890 GC (Palo Alto, CA, USA) equipped with a 
Gerstel MPS autosampler, coupled with an Agilent 7000C MSD detector (Palo Alto, CA, USA). The 
chromatographic separation was performed on a HP-5MS capillary column (30 m × 0.25 mm, film 
thickness of 0.17 μm), and the following temperature program was used: 60 °C hold for 3 min, 
increased to 210 °C at a rate of 4 °C/min, held at 210 °C for 15 min, increased to 300 °C at a rate of 10 
°C/min, and finally held at 300 °C for 15 min. Helium was used as the carrier gas at a constant flow 
of 1 mL/min. The data was analyzed using a MassHunter Workstation B.06.00 SP1, with identification 
of the individual components performed by comparison with the co-injected pure compounds and 
by matching the MS fragmentation patterns and retention indices with literature data or commercial 
mass spectral libraries (NIST/EPA/NIH 2008; HP1607 purchased from Agilent Technologies, Palo 
Alto, CA, USA). 
2.3.2. GC-FID Analysis of TC Essential oil 
The GC-FID analysis of a TC essential oil solution in hexane (dilution ratio 1:200 v/v, injection 
volume 1 μL) was carried out by using an Agilent 4890N (Palo Alto, CA, USA) equipped with a FID 
and an HP-5 capillary column (30 m × 0.25 mm, film thickness of 0.17 μm). The column temperature 
was held at 60 °C for 3 min, then increased to 210 °C at a rate of 4 °C/min and held at 210 °C for 15 
min, then increased to 300 °C at a rate of 10 °C/min, and finally held at 300 °C for 15 min. Injector and 
detector temperatures were 250 °C. Helium was used as the carrier gas at a flow rate of 1 mL/min. 
The compound quantification in the essential oil was carried out by the internal normalization of FID 
chromatogram. Results were expressed as a relative percentage. 
A hydrocarbon mixture of n-alkanes (C9–C22) was analyzed separately under the same 
chromatographic conditions to calculate the retention indexes with the generalized equation by Van 
del Dool and Kartz [26], Ix = 100[(tx − tn)/(tn+1 – tn) + n], where tn and tn+1 are the retention times of the 
reference n-alkane hydrocarbons eluting immediately before and after chemical compound “X”; tx is 
the retention time of compound “X”. 
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2.3.3. Targeted LC-MS/MS Analysis of CLP Extract 
Liquid chromatography was performed by using a Flexar UHPLC AS system (Perkin-Elmer, 
Shelton, CT, USA) equipped with a degasser, Flexar FX-10 pump, autosampler, and PE 200 column 
Oven interfaced to an AB Sciex (Foster City, CA, USA) API4000 Q-Trap instrument as in Manconi et 
al. [23]. Briefly, a CLP extract solution in methanol (dilution ratio 1:100 w/v) was filtered through 0.20 
μm syringe PVDF filters (Whatmann International Ltd., Little Chalfont, Buckinghamshire, UK) and 
injected (5 μL) in the LC-MS/MS system. The chromatographic separation was carried out on a 
XSelect HSS C18 column (Waters, Milford, MA, USA) (100 × 2.1 mm i.d., 2.5 μm d). Mobile phase A 
was water containing 0.1% formic acid, while mobile phase B was acetonitrile containing 0.1% formic 
acid. Elution was carried out at 41 °C according to the following flow and solvent gradient: 0–4 min, 
isocratic 0% solvent B and the flow changes from 300 μL to 350 μL; 4–6 min, linear gradient 0–12% B 
and the flow achieves 400 μL/min; 6–12 min, linear gradient 12–20% B and flow constant at 400 
μL/min; 16–17 min, linear gradient 20–100% B and flow retrieves to 300 μL/min. 
All quantitative data were elaborated with the aid of the Analyst software. Results were 
expressed as μg/mg of the freeze-dried extract. 
2.4. Vesicle Preparation and Characterization 
Soybean lecithin was purchased from Galeno (Potenza, Italy). Glycerol, propylene glycol, and 
all other products were purchased from Sigma-Aldrich (Milan, Italy). 
2.4.1. Vesicle Preparation 
The TC essential oil or CLP extract were incorporated into liposomes, glycerosomes, and 
propylen glycol-penetration enhancer containing vesicles (PG-PEVs) using an environmentally-
friendly technique avoiding the use of organic solvents (Table 1). 
Table 1. Composition of TC essential oil and CLP extract loaded liposomes, glycerosomes, and PG-PEVs. 
Sample Soy lecithin (mg) 
Essential oil/Extract 
(mg) 
Water 
(mL) 
Glycerol 
(mL) 
PG 
(mL) 
TC liposomes 60 10 1.0 -- -- 
TC glycerosomes 60 10 0.5 0.5 -- 
TC PG-PEVs 60 10 0.5 -- 0.5 
CLP liposomes 60 10 1.0 -- -- 
CLP glycerosomes 60 10 0.5 0.5 -- 
CLP PG-PEVs 60 10 0.5 -- 0.5 
Liposomes were formulated by dispersing lecithin (60 mg/mL) and TC essential oil or CLP 
extract (10 mg/mL) in bidistilled water. The dispersions were sonicated (30 cycles, 5 s ON and 2 s 
OFF; 13 microns of probe amplitude) by using a Soniprep 150 (MSE Crowley, London, UK). 
Glycerosomes were formulated by dispersing lecithin (60 mg/mL) and TC essential oil or CLP 
extract (10 mg/mL) in a water:glycerol blend (50:50 v/v). The dispersions were sonicated (30 cycles, 5 
s ON and 2 s OFF; 13 microns of probe amplitude) by using a Soniprep 150 (MSE Crowley, London, 
UK). 
PG-PEVs were formulated by dispersing lecithin (60 mg/mL) and TC essential oil or CLP extract 
(10 mg/mL) in a water:propylene glycol blend (50:50 v/v). The dispersions were sonicated (30 cycles, 
5 s ON and 2 s OFF; 13 microns of probe amplitude) by using a Soniprep 150 (MSE Crowley, London, 
UK). 
2.4.2. Vesicle Characterization 
The average diameter and polydispersity index (PI; a measure of width of the size distribution) 
of the vesicles were determined by Photon Correlation Spectroscopy using a Zetasizer nano (Malvern 
Instruments, Worcestershire, UK). Samples (n = 6) were backscattered by a helium-neon laser (633 
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nm) at an angle of 173° and a constant temperature of 25 °C. The zeta potential of the vesicles, an 
indicator of the stability of vesicular dispersions, was estimated by using the Zetasizer nano by means 
of the M3-PALS (phase analysis light scattering) technique, which measures the particle 
electrophoretic mobility. Prior to the analysis, the samples (10 μL) were diluted with the appropriate 
mixture (i.e., water or water/glycerol or water/propylene glycol, 10 mL). A long-term stability study 
was performed by monitoring the vesicle size, polydispersity index, and zeta potential over 60 days 
at 4 °C. 
2.5. Cytotoxicity Assay 
Human gingival fibroblasts (HGFs) were isolated from biopsies of gingiva from human adult 
patients, all informed and consenting (ethical approval by ethics committee review boards for human 
studies in Sassari, ref. number 2034/2014). The samples were disinfected in poly(vinylpyrrolidone)–
iodine solution (PVP-I, Sigma Aldrich Chemie GmbH, Munich, Germany) for 3 min and washed 
twice in Hank’s balanced salt solution (HBSS; Sigma Aldrich Chemie GmbH, Munich, Germany). 
Dissociation was then performed by mechanical fragmentation and enzymatic digestion in 0.1% type 
I collagenase (Gibco Life Technologies, Grand Island, NY, USA) for 120 min at 37 °C in Hanks 
balanced salt solution (HBSS; Sigma Aldrich Chemie GmbH, Munich, Germany). The cell suspension 
was filtered through a 70 μm cell strainer (Euroclone, Milano, Italy) and centrifuged at 1800 rpm for 
10 min. Then, the cells were transferred in culturing medium containing DMEM medium (Invitrogen, 
Carlsbad, CA, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS, Invitrogen, 
Carlsbad, CA, USA), 200 U/mL penicillin, and 0.1 mg/mL streptomycin. The cells seeded in culture 
flasks were placed at 37 °C in a humidified atmosphere containing 5% CO2. The MTT assay was used 
to analyze the cytotoxic effect of the two extracts on fibroblasts, according to recently published 
papers [27,28]. In total, 1 × 104 cells were suspended in 96-well plates diluted in 200 μL of medium. 
After attachment, the cells were incubated for 48 h with 200 μL of medium containing the different 
compounds to be tested at different concentrations (1, 10, 100 μg/mL). After 48 h, the medium was 
removed and 100 μL of 0.65 mg/mL MTT were added in each well and incubated for 3 h. The MTT 
(yellow tetrazolium salt) was enzymatically converted into purple formazan precipitate by viable 
cells. The concentration of formazan represents an indicator of viable cells. After removing the 
medium, 100 μL of DMSO was added to dissolve the formazan participates. Finally, absorbance was 
detected at the 570 nm wavelength by an ELISA plate reader (Gemini EM Microplate Reader; 
Molecular devices, San Jose, CA, USA). Control untreated cells were incubated for 48 h with the 
medium alone (100% viability). 
The relative viability of the cells, as compared to the control, was calculated using the following 
formula: 
% cell viability = (OD570 of treated cells) × 100%/(OD570 of control cells). 
The data were entered using SPSS Version 2.0 (IBM SPSS, 2013). An ANOVA test was used to 
analyze the data obtained, and the level of significance was set at p < 0.001. 
2.6. Antimicrobial Assays 
Antimicrobial analysis was conducted using the following planktonic microorganisms: S. 
mutans (ATCC 35668); C. albicans (ATCC 10231). 
2.6.1. Preparation of the Microbial Inocula 
Stock culture of each tested microorganisms maintained at −20 °C was recovered by 
subculturing on nutrient agar plates using Mueller Hinton Agar (MHA) (Sigma-Aldrich) with the 
addition of sheep blood for S. mutans, while for C. albicans, Sabouraud Destrose (IFU) was used in 
accordance with the European Committee on Antimicrobial Susceptibility Testing. One or two 
colonies of the same morphological type were selected from the plates and aseptically transferred 
into test tubes containing 2 mL of sterile saline by means of a sterile loop. McFarland standard was 
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used as a reference to adjust the turbidity of the bacterial suspensions to the required range for 
bioassays (1–2 × 108 UFC/mL). 
2.6.2. Disc Diffusion Method 
The assessment of the antimicrobial activity of the raw extracts and that of the corresponding 
extracts incorporated in the nanovesicles was carried out using the disc diffusion method [12]. Sterile 
Whatman filter paper discs of a 6 mm diameter were impregnated with 15 μL of each sample in a 
sterile biological safety cabinet. The discs were then aseptically placed in the center of inoculated 
petri plates (9 cm in diameter) uniformly spread with 0.1 mL of the overnight culture of each 
microorganism. The plates were refrigerated at 4 °C for 2 h to allow the samples to diffuse into the 
agar medium and then incubated upside down at 37 °C for 48 h. The tests were conducted in triplicate 
and the measurement of the inhibition zones was read at 24 and 48 h. A paper disc without 
antimicrobials was used as a positive control for the growth of the microorganisms. Gentamycin (10 
mg/disc; Gibco) and Ketoconazole (10 mg/disc; Janssen Pharmaceutics) were used as negative 
controls for bacterial and fungal strains, respectively. The scale applied for the measurement of the 
antimicrobial activity as the zone of inhibition was as follows (disc diameter included): Not sensitive 
(−) for total zone diameters ≤ 12 mm; sensitive (+) for diameters ranging between 12 and 19 mm; 
extremely sensitive (+++) for zone diameters ≥ 20 mm. The bioassays were conducted in a biological 
safety cabinet in accordance with the protocols of Clinical and Laboratory Standards Institute (CLSI), 
formerly National Committee for Clinical Laboratory Standards [29]. 
2.6.3. Minimum Inhibitory Concentration (MIC), Minimum Bactericidal Concentration (MBC), and 
Minimum Fungicidal Concentration (MFC) 
The MIC, MBC, and MFC of the raw extracts and that of the nanovesicles against S. mutans and 
C. albicans were determined using a broth microdilution method according to standard guidelines 
[30,31]. In 96-well microtiter trays, each sample was subjected to two-fold serial dilutions (2.5–0.078 
mg/mL) in MHA or Sabouraud Destrose Liquid Medium for bacteria and yeasts, respectively, and 
the wells were inoculated with 103 to 104 bacteria or yeast cells from 24 h broth cultures; the plates 
were then incubated at 37 °C for 24 h. The MIC was defined as the lowest concentration of each 
sample that completely inhibited microorganisms’ growth. MBCs and MFCs were determined by 
sub-culturing small aliquots (10 μL) of the suspensions from wells not showing microbial onto solid 
media (MHA and Sabouraud Dextrose Agar for the bacteria and the yeast, respectively). The MBC 
and MFC values were defined as the lowest concentrations that produced no colonies on the agar 
plates. 
2.6.4. Microbial Killing Rates by Time-Kill Assay 
Time-dependent killing of the raw extracts and the nanovesicles were identified against 
standardized microbial inocula of S. mutans and C. albicans in a liquid medium not supporting cell 
growth [32]. Microorganisms in a logarithmic phase of growth were centrifuged at 2000 rpm for 10 
min, washed in phosphate-buffered saline (PBS, Dulbecco A; pH 7.3), and resuspended at the density 
of 5 × 105 to 1 × 106 colony-forming units (cfu)/mL in appropriate volumes of PBS containing suitable 
concentrations of each bioactive agent. An inoculum of microorganisms in PBS without any 
antimicrobial was used as a control and was included in each assay. After the inoculation, the 
suspensions were incubated at 37 °C. At time zero and at predetermined intervals (1, 2, and 3 h), 0.5 
mL of the mixtures were aseptically removed and subjected to serial 10-fold dilution in PBS; aliquots 
of 1 mL of the appropriate dilutions were then placed in petri dishes (90 mm diameter) and 19 mL of 
molten MHA or Sabouraud Dextrose were added for S. mutans and C. albicans, respectively, swirling 
thoroughly. The plates were then incubated for 48 h at 37 °C; the number of viable microorganisms 
at each time was evaluated by counting plates with 30 to 300 colonies. These evaluations were done 
in duplicate. 
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2.7. Transmission Electron Microscopy 
The ultramorphology of S. mutans and C. albicans after contact with the raw extracts and the 
extract loaded vesicles, using MIC values, was studied using transmission electron microscopy 
(TEM). Cell suspensions of S. mutans and C. albicans were aseptically removed from the cultures. Each 
culture was divided into two groups, one of which was left untreated (control), while the other group 
(treated) was further subdivided into four subgroups for microorganism species, each of which was 
treated at the MIC of each bioactive agent as for the time-kill assay. Thereafter, both the subgroups 
and the controls were incubated for 24 h at 37 °C. Subsequently, all the cell material was harvested 
by centrifugation and prefixed with a 2.5% glutaraldehyde solution overnight at 4 °C. As in previous 
studies under TEM [33–35], the pellets were washed in cacodylate buffer, pH 7.4, post-fixed in 1% 
osmium tetroxide for 30 min, and washed twice in cacodylate buffer, dehydrated using ethanol in 
increasing concentrations (25–100%), embedded in epoxy resin to make the blocks of the cell pellets, 
cut into ultra-thin sections (80 μm in thickness) using a Diatome diamond knife, and stained with 
lead citrate and uranyl acetate. Samples were placed on 50 mesh copper grids and observed under 
TEM (Zeiss 109 EM Turbo, Königsallee, Göttingen, Germany). 
3. Results 
3.1. Chemical Composition 
After GC-MS analysis, a total of 14 compounds were identified, representing 99% of the whole 
TC essential oil. The chemical composition was dominated by carvacrol, which represents 90% of the 
total active ingredients contained in the essential oil (Table 2). 
Table 2. Main components of TC essential oil as analyzed by GC/GC-MS techniques. Results are 
expressed as relative percentages obtained by internal normalization of FID chromatogram. RI: 
experimental retention indexes on HP5 column. 
Main components of TC essential oil A% RI 
p-cymene 1.1 1022.9 
limonene 0.2 1026.5 
1,8-cineole 0.6 1028.8 
γ-terpinene 0.4 1066.5 
linalool 1.6 1100.9 
camphor 0.1 1142.5 
borneol 0.7 1165.1 
terpinen-4-ol 1.1 1176.9 
α-terpineol 0.2 1192.7 
Thymol 0.5 1294.6 
carvacrol 90.1 1306.5 
carvacrol acetate 0.1 1375.3 
cariophyllene 1.0 1419.3 
cariophyllene oxide 1.3 1586.2 
The chemical characterization of CLP extract was carried out by targeted LC-MS/MS analysis. 
Thirteen compounds belonging to flavanones and phenolic acids were identified and quantified, as 
previously reported [23]. The main compound detected in the extract was quinic acid with a 
concentration that matched 220 μg/mg of freeze-dried extract. 
3.2. Vesicles Characterization 
TC essential oil and CLP extract were incorporated in different types of phospholipid vesicles, 
namely liposomes, glycerosomes, and PG-PEVs (Table 1), aiming at protecting the bioactive 
components from possible degradation and controlling their release. 
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The physical characteristics of the different vesicle systems are reported in Table 3. TC essential 
oil and CLP extract loaded liposomes were around 86 and 137 nm, respectively. The addition of 
glycerol (glycerosomes) or propylene glycol (PG-PEVs) led to an increase in size, which was more 
significant when using TC essential oil. Regardless of the composition of the vesicles, the 
polydispersity index, which is a dimensionless measure of the broadness of the size distribution, was 
always ≤0.3, thus indicating a homogeneous distribution of the vesicle size in the dispersions. The 
zeta potential of the vesicles was generally highly negative, predicting a good stability of the vesicle 
dispersions during storage. Indeed, the long-term stability studies (60 days at 4 °C) showed that the 
variation in the vesicle size, polydispersity index, and zeta potential were never greater than 10%. 
Table 3. The main physico-chemical properties of TC and CLP loaded liposomes, glycerosomes, and 
PG-PEVs are reported: Mean diameter (MD), polydispersity index (PI), and zeta potential (ZP) 
estimated by dynamic and electrophoretic light scattering. Mean values ± standard deviations were 
obtained from 8 replicates. 
Sample MD (nm) PI 
ZP 
(mV) 
TC liposomes 86 ± 12 0.25 –72 ± 12 
TC glycerosomes 479 ± 40 0.23 –49 ± 3 
TC PG-PEVs 337 ± 45 0.24 –50 ± 1 
CLP liposomes 137 ± 16 0.26 –43 ± 4 
CLP glycerosomes 180 ± 16 0.30 –51 ± 9 
CLP PG-PEVs 218 ± 28 0.30 –65 ± 5 
3.3. Cytotoxicity Assay 
HGFs were treated or not (control) with different concentrations of TC and CLP for 48 h. The 
cell viability in the presence of the investigated compounds was assayed. Using one-way ANOVA, 
no significant differences (p < 0.001) were found between the treated cells and control cells. In 
addition, both TC liposome (100 μg/mL) and TC PG-PEVs (100 μg/mL), as well as CLP liposome (100 
μg/mL) treated cells exhibited a significant increase in cell viability, as compared to untreated cells 
(Figures 1 and 2), indicative of a proliferative effect. 
 
Figure 1. MTT assay after 48 h exposure to different concentrations (100, 10, 1 μg/mL) of TC essential 
oil, TC liposomes, TC glycerosomes, and TC PG-PEVs. ANOVA analysis showed high significance 
values (* p < 0.001) for liposomes and PG-PEVs at 100 μg/mL vs. the untreated control (0; 100% 
viability). 
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Figure 2. MTT assay after 48 h exposure to different concentrations (100, 10, 1 μg/mL) of CLP essential 
oil, TC liposomes, TC glycerosomes, and TC PG-PEVs. ANOVA analysis showed high significance 
values (* p < 0.001) for liposomes at 100 μg/mL vs. the untreated control (0; 100% viability). 
3.4. Disc Diffusion Method 
Antimicrobial susceptibility tests on discs impregnated with 15 μL of each sample showed that 
TC had an inhibition capacity towards the tested microorganisms. Also, this preliminary screening 
demonstrated that TC in the nanovesicles had similar antibacterial effects to the raw essential oil. The 
raw CLP extract did not display any antimicrobial activity, neither against S. mutans nor C. albicans. 
Conversely, when CLP extract was delivered by the nanovesicles, the antimicrobial activity against 
S. mutans increased, while it remained ineffective against C. albicans. In Tables 4 and 5, the 
antimicrobial activity and 95% CI of the halo inhibition diameters (mm) against S. mutans and C. 
albicans are reported. 
Table 4. Descriptive statistics for the antimicrobial activity of TC essential oil against the 
microorganisms using the disc diffusion assay. 
TC essential oil 
S. mutans C. albicans 
Mean ± SD 95%CI Mean ± SD 95%CI 
Raw oil 12 ± 0 12–12 12 ± 0.5 10.76–13.24 
Liposomes 13 ± 0 13–13 0 ± 0 0–0 
Glycerosomes 11 ± 0 11–11 11.83 ± 0.29 11.12–12.6 
PG-PEVs 0 ± 0 0–0 9 ± 1.73 4.69–13.30 
Gentamicin 14 ± 0 14–14 - - 
Ketoconazole - - 11.33 ± 0.58 9.89–12.77 
Table 5. Descriptive statistics for the antimicrobial activity of CLP extract against the microorganisms 
using the Disc Diffusion assay. 
CLP extract 
S. mutans C. albicans 
Mean ± SD 95%CI Mean ± SD 95%CI 
Raw extract 0 ± 0 0–0 0 ± 0 0–0 
Liposomes 8.97 ± 0.58 8.82–9.11 0 ± 0 0–0 
Glycerosomes 14 ± 0 14.0–14.0 0 ± 0 0–0 
PG-PEVs 10 ± 0 10–10 0 ± 0 0–0 
3.5. MIC-MBC/MFC 
Raw TC essential oil showed high activity against S. mutans with an MIC and MBC of 0.5 mg/mL 
(Table 6). Raw CLP extract inhibited S. mutans with an MIC and MBC of 0.625 mg/mL. However, TC 
essential oil and CLP extract loaded in liposomes were not effective against the bacteria with an MIC 
range >2.5 mg/mL, whereas MICs for TC essential oil and CLP extract loaded in glycerosomes and 
PG-PEVs were <0.078 mg/mL, meaning that no bacterial growth was achieved even at the lower 
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concentrations. Regarding C. albicans, MIC and MFC values for the raw TC essential oil were the most 
effective among the samples tested (Table 7). TC essential oil loaded vesicles were not effective 
against the yeast (MIC and MBC >2.5 mg/mL), regardless of how they were formulated. MIC and 
MFC values for raw CLP against C. albicans were 0.625 mg/mL, while all vesicles loading CLP extract 
were not able to inhibit the yeast. 
Table 6. Minimum inhibitory concentrations (MICs), minimum bactericidal concentrations (MBCs), 
and minimum fungicidal concentrations (MFCs) (expressed as mg/mL) of TC essential oil and TC 
loaded in nanovesicles against S. mutans and C. albicans determined by the broth microdilution 
method. 
Strain 
Raw essential oil Liposomes Glycerosomes PG-PEVs 
MIC MBC/MFC MIC MBC/MFC MIC MBC/MFC MIC MBC/MFC 
S. mutans 0.5 0.5 >2.5 >2.5 <0.078 <0.078 <0.078 <0.078 
C. albicans 0.25 0.5 >2.5 >2.5 >2.5 >2.5 >2.5 >2.5 
Table 7. Minimum inhibitory concentrations (MICs), minimum bactericidal concentrations (MBCs), 
and minimum fungicidal concentrations (MFCs) (expressed as mg/mL) of CLP extract and CLP 
loaded in nanovesicles against S. mutans and C. albicans determined by the broth microdilution 
method. 
Strain 
Raw essential oil Liposomes Glycerosomes PG-PEVs 
MIC MBC/MFC MIC MBC/MFC MIC MBC/MFC MIC MBC/MFC 
S. mutans 0.625 0.625 >2.5 >2.5 <0.078 <0.078 <0.078 <0.078 
C. albicans 0.625 0.625 >2.5 >2.5 >2.5 >2.5 >2.5 >2.5 
3.6. Time-Kill Assay 
A time-kill assay was used to further evaluate the antimicrobial activities of the samples. Despite 
its subjective character, the MIC assay is used to judge the performance of the other methods of 
susceptibility testing [36]. In our case, MICs for raw TC essential oil and loaded in nanovesicles 
against S. mutans ranged from <0.078 mg/mL to >2.5 mg/mL, while MICs against C. albicans ranged 
from 0.25 mg/mL to >2.5 g/mL. Thus, because of the wide range of MICs, we identified the MICs of 
raw TC against S. mutans (0.5 mg/mL) and C. albicans (0.25 mg/mL) as suitable concentrations to 
conduct a time-course of microbial viability for TC essential oil loaded in vesicles (Figure 3). 
Similarly, microbial viability for non-incorporated CLP extract and that loaded in vesicles against the 
target microorganisms was conducted as MICs for the bacteria and the yeast (0.625 mg/mL). The 
results demonstrated that the inoculum of S. mutans was reduced to 11% within 3 h after the addition 
of raw TC essential oil; and C. albicans’ viability was inhibited to 30% after 3 h of exposure to the raw 
oil. Raw CLP extract reduced the viability of S. mutans to 18%, whereas it was not able to inhibit the 
yeast significantly within the 3 h of this experimentation. The nanovesicles, regardless of the loaded 
TC essential oil or CLP extract, at the tested concentrations of MICs could arrest neither the growth 
of S. mutans nor that of C. albicans, except for CLP in PG-PEVs, which showed an inhibition ability 
towards the yeast (Figure 3). 
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Figure 3. Time-kill curves of S. mutans and C. albicans treated with TC essential oil, CLP extract, and 
their nanovesicles.  
3.7. Transmission Electron Microscopy (TEM) 
3.7.1. Untreated S. mutans 
Under TEM, untreated S. mutans appeared in clusters and showed an intact and well-defined 
cell wall (CW), plasma membrane (PM), and cytoplasmic space. The nucleoid could be seen in some 
cells located in an eccentric position in the cytoplasm (Figure 4Α). 
 
Figure 4. (Α) Untreated S. mutans shows an intact and well-defined cell wall (CW), plasma membrane 
(PM), and cytoplasmic space with a nucleoid (N). (Β) When treated with TC essential oil, S. mutans 
appears swollen and degenerated with clear evidence of rupture of the CW and PM up to cell 
disintegration. (C) After contact with CLP extract, S. mutans displays features of degeneration 
comparable to those described in the cells treated with TC essential oil.(D) Regardless of the extract 
loaded, after contact with liposomes, S. mutans showed a well-conserved morphology in comparison 
to the control, whereas (Ε) after contact with glycerosomes, the cells appear swollen and show the 
enlargement of the wideness between CW and PM, and (F) after contact with PG-PEVs, the cells are 
surrounded by dense globules infiltrating the CW with perforation of the CW and PM. Other cells 
appear clearly disintegrated in the cluster. 
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3.7.2. Treated S. mutans 
When treated with TC essential oil, the cluster of S. mutans showed a high range of degenerated 
cells. The cells appeared swollen and deformed with a clearly observed rupture of CW and PM in 
addition to cytoplasm degeneration up to cell disintegration (Figure 4Β). After contact with CLP 
extract, S. mutans showed morphological aspects of degeneration comparable to those described in 
the cells treated with TC essential oil (Figure 4C). After contact with liposomes (Figure 4D), S. mutans 
showed a well-conserved morphology in comparison to the control, whereas after contact with 
glicerosomes (Figure 4Ε), the cells showed characteristic enlargement of the wideness between the 
CW and PM, and after PG-PEV contact (Figure 4F), the cells appeared surrounded by dense globules 
infiltrating the CW and displayed perforation of the CW and membrane. Occasional aspects of cell 
degeneration were also reported using PG-PEVs. 
3.7.3. Untreated C. albicans 
The ultrastructure of the yeast shows a prominent and amorphous CW surrounding the inner 
PM and the dark intracytoplasmatic space (Figure 5Α). Microfibrils of β glucans could be seen in the 
outer layer of the membrane. Microfibrils formed a wide-meshed network of fibrils extending into 
the cell wall (Figure 5Β). 
 
Figure 5. (Α) Untreated C. albicans shows a prominent and amorphous CW surrounding the PM and 
the dark intracytoplasmatic space. (Β) Characteristic microfibrils of β glucans can be observed in the 
outer layer of the membrane. Microfibrils are intermeshed into thicker bundles, forming a wide-
meshed network of fibrils extending into the cell wall. (C) After 24 h of contact with TC essential oil, 
the yeast show features compatible with a fungicidal activity. The photograph shows alteration in the 
shape and wideness of the CW with rupture of the PM and cytoplasm fragmentation of the yeast. (D) 
In other cells, the PM appears ruffled and vacuoles of medium density and shape could be detected 
within the cytoplasm. (Ε) Protoplasms treated with CLP extract show an enlargement of the wideness 
between the CW and PM. (F) No morphological alterations could be observed neither in the PM nor 
in the cytoplasm, suggesting a fungistatic rather than a fungicidal effect of CPL extract.  
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3.7.4. Treated C. albicans 
After 24 h contact with TC essential oil, C. albicans showed an alteration in the shape and 
wideness of the CW with rupture of the PM together with cytoplasm fragmentation and features 
compatible with cell death (Figure 5C). Other cells showed an irregularly ruffled PM with vacuoles 
(V) of medium density and shape in the cytoplasm (Figure 5D). Protoplasms treated with CLP extract 
showed an enlargement of the wideness between the CW and PM (Figure 5Ε). However, no 
morphological alterations could be observed, neither in the PM nor in the cytoplasm, suggesting a 
fungistatic rather than a fungicidal effect of CPL towards C. albicans (Figure 5F). After contact with 
liposomes (Figure 6Α), the cells showed a quite conserved morphology in comparison to the control, 
while after contact with glycerosomes (Figure 6Β) and PG-PEVs (Figure 6C), halos of different 
thicknesses delimiting and infiltrating the CW were commonly observed in addition to occasional 
aspects of cell degeneration using PG-PEVs. 
 
Figure 6. (Α) After contact with liposomes, the cells show quite conserved morphology in comparison 
to the control, while (Β) after contact with glycerosomes and (C) PG-PEVs, halos of different 
thicknesses delimiting and infiltrating the CW are common features in the cells, with some occasional 
aspects of cell degeneration using PG-PEVs. 
4. Discussion 
Despite developments in the understanding of biological and physico-chemical mechanisms, 
dental caries remains one of the most common diseases of our era, affecting 60% to 90% of children 
and 100% of adults worldwide [37]. The main methods of prevention have been based on the daily 
use of fluoride toothpaste, a reduction in both the amount and regularity of sugar intake, and 
drinking fluoridated water [6,38,39]. However, the effect of fluorine is mainly to increase resistance 
to demineralization and promote remineralization in teeth, while its antimicrobial activity has not 
generally been considered significant [40,41]. Hence, antimicrobial agents, directly interfering with 
the metabolism of dental plaque, are required in addition to mechanical cleaning [8,42]. In particular, 
the poor specificity of chemical agents [43] and global antimicrobial resistance [44–46] require new 
and safe molecules able to target microorganisms selectively [47]. 
Given this context, we chose to study the antimicrobial capacity of TC essential oil and CLP 
extract with the intention of identifying new natural agents taken from Sardinia’s biodiversity, which 
could be useful against S. mutans and C. albicans. The extracts were incorporated in different 
phospholipid nanovesicles with the intent to protect the bioactive molecules from degradation and 
volatility, while modulating their delivery over time and improving its bioavailability and potency 
at the target site [48]. Because in previous studies we had found that glycerosomes and PG-PEVs 
were effective in transporting bioactive polyphenols [22,23], this study had the intention to test the 
possibility that the same carriers would be useful in delivering antimicrobial TC essential oil and CPL 
extract. The vesicle systems used in this experiment demonstrated a homogeneous distribution of 
particle size (PI ≤ 0.3) and a highly negative zeta potential, which, as a result of the index of the 
magnitude of repulsive interaction between the colloidal particles, ensured the high stability of the 
nanodispersions [23,49]. Regardless of their antimicrobial aggressiveness, none of the samples 
examined, at the concentrations used, showed cytotoxicity in gingival fibroblasts. This outcome 
confirms the use of Thyme biomolecules as safe compounds (GRAS) [50] and contributes to the 
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understanding of Citrus flavonoids in the field of modern medicine. In addition, the data confirm the 
possible use of phospholipid nanovesicles as oral systems [51]. 
The data also suggest that at selected doses, there will be a selective cytotoxicity of the natural 
extracts towards microbes due to the fundamental differences in composition and structure of the 
host cells, compared to those of bacteria and yeasts [52]. TC essential oil was the most effective 
antimicrobial. The very high presence of the phenol carvacrol in TC essential oil (90.1%) could explain 
the major activity of this fraction against S. mutans and C. albicans [15,17,53,54]. However, a 
synergistic interaction of the oxigenate, terpene (1.1%); the bicyclic sesquiterpene, caryophyllene 
oxide (1.3%); the terpenes, p-cymene and terpinen-4-ol (1.1%); and thymol (1.1%) could also be 
involved in the antimicrobial ability [55,56]. In addition, a direct effect of caryophyllene oxide has 
been reported against Streptococcus [57]. With regards to carvacrol, its high toxicity against 
microorganisms derives from its hydrophobicity and allows it to partition the lipids of the cell 
membrane [58], making the membrane destabilized and permeable [53,59,60], and thus leading to the 
leakage of ions and other cell constituents, the impairment of several enzyme systems [17,61], and 
also endoplasmic reticulum stress [15]. Toxicity requires a pH < pKa, in which case the peptide is 
fully positively charged, capable of interacting with the anionic membrane of the cells [58], and thus 
able to enter the phospholipid bilayer of the membrane. Accordingly, we used culture media with a 
pH range of 5.7–7 ± 0.1, which allowed the pH dependence of carvacrol [53,59], pKa phenolic OH 
group ∼10.9 [62]. S. mutans and C. albicans were severely inhibited by the raw essential oil as shown 
by the MBC-MFC/MIC ratio and the time-kill kinetics (Tables 6 and 7, Figure 3). In particular, the 
MIC and MFC, in addition to the killing kinetics, demonstrated that the TC essential oil was the most 
effective fungicidal, killing up to 70% of the yeasts and not just arresting their growth. These data 
were supported by the morphological analysis of S. mutans and C. albicans showing cell features 
compatible to lethal and not inhibitory effects. 
Regarding CLP extract, the chromatographic technique coupled with mass spectrometry 
revealed it was rich in flavanones, flavones, and phenolic acid mainly represented by quinic acid 
(219.7 μg/mg), followed by neoeriocitrin (46.5 μg/mg), neohesperidin (44.6 μg/mg), naringin (23.8 
μg/mg), and sinapic acid (30.1 μg/mg) [23]. Although the compounds in CLP extract belong to a 
different class with respect to the components found in TC essential oil, they exerted the antimicrobial 
activity in a similar way by reducing the growth and viability of S. mutans, as demonstrated by the 
MIC and time-kill assays. This result is not in agreement with the disc diffusion assay, which seemed 
to demonstrate that CLP extract was unable to inhibit S. mutans. We could explain the data as a 
misinterpretation of the therapeutic efficacy of the extract using the agar disc. In fact, it is well known 
that the inhibition halo is an effect of the capacity of the antimicrobial agent to diffuse into the agar, 
inhibiting germination and growth of the test microorganism. However, it is also possible that 
antimicrobial cationic agents could combine with the anionic agar polysaccharide gel [63], making 
this method imprecise in effectively predicting the capacity of a compound. Despite its bactericidal 
ability, CLP extract was not effective as fungicidal compound, as was evidenced by the MIC and 
time-kill assay (Table 7 and Figure 3). These data, in addition to the TEM images, could suggest a 
fungistatic rather than a fungicidal effect of CLP extract towards C. albicans. To explain the different 
susceptibility of the yeast to the extracts, a specific toxicity of some of the TC essential oil’s active 
fractions, in particular, carvacrol [15,17,53,54], could be supposed. A proteic partner in the 
phospholipid bilayer of the fungal membrane has been proposed for carvacrol. This interplay is 
similar to most antifungal therapies, e.g., azoles among others, which lead to a fungistatic effect [64]. 
In addition, antifungal therapies have side effects in humans and cause an increase in Candida 
resistance [64–68]. Thus, although further studies are necessary, among them an assessment of 
whether emerging resistance could be developed using multiple exposures to TC essential oil, the 
fungicidal ability of this natural drug should be considered as a safe alternative to chemicals. 
Regarding phospholipid vesicles, TC essential oil and CLP extract loaded in liposomes did not 
display any antibacterial activity against S. mutans (MIC > 2.5 mg/mL). Conversely, TC essential oil 
and CLP extract loaded in glycerosomes and PG-PEVs resulted in MICs that were unquantifiable, 
meaning that no bacteria growth was detectable under these experimental conditions, even at the 
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lowest concentrations. Thus, it could be possible that glycerosomes and PG-PEVs exerted their 
antibacterial activities after the 3 h time limit of the kill assay, at which point the raw extracts were 
effective against the bacteria. It is likely that in some way, the vesicles might slow the release of the 
loaded bioactive molecules within that time. In addition, we could suppose that the extract 
transported by the vesicles was not the only factor in determining the toxicity against S. mutans. 
Under TEM, the prime target of glycerosomes and PG-PEVs seemed to be the bacterial CW, which 
was surrounded by dense halos with a tendency to reach the bacterial membrane. Although the 
vesicles may be too large to penetrate the bacterial envelope, it is likely that the co-surfactant 
molecules partition the lipid compartments of the bacterial cells. This may occur either directly (from 
the vesicles to the bacteria) or indirectly (through the aqueous phase). As larger, lipophilic co-solvent 
molecules, such as glycerol and propylenglycol, have a higher affinity for lipidic compartments than 
smaller, more hydrophilic compounds, they might have contributed to the activity of the system [69]. 
This consideration may explain the different abilities and morphological features of phospholipid 
vesicles against S. mutans. 
Regarding the antimicrobial activity against C. albicans, glycerosomes and PG-PEVs displayed a 
fungistatic activity, highlighting a greater resistance of the yeast membrane in comparison to that of 
the bacteria. 
5. Conclusions 
On the bases of the data obtained in this study, TC essential oil possesses the highest 
antimicrobial capacity against S. mutans and C. albicans. CLP extract showed bactericidal properties 
against S. mutans, but it was not effective as a fungicidal compound. Regardless of the extract loaded, 
glycerosomes and PG-PEVs behaved similarly against both the bacterium and the yeast. 
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